Icon

NOURIANZ (nda022075)- (20MG,40MG)

ISTRADEFYLLINE KYOWA KIRIN
20MG,40MG
No No
2028-Jan-28 2024-Aug-27
None None
None No
NOURIANZ is an adenosine receptor antagonist indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes.
0 0 0
Total Other Developers 1
Drugs with Suitability No
20MG ** ** - - -
40MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.